The FDA is proposing to require manufacturers of cranial electrotherapy stimulators to submit pre-market approval applications if their devices are intended to treat depression. The federal safety watchdog said it’s also proposing to down-classify CES devices aimed at treating insomnia and anxiety from Class III, which would also require PMA applications, to Class II subject to […]